Media Release
Ajman, Feb 22: Owing to high incidence and cost of cardiovascular disease, clinicians target primary prevention and recommend that providers evaluate patients for cardiac risk factors that may warrant medical treatment. Therefore, multiple perspectives and broad insight are urgently needed to gain a deeper understanding of multiple risk factor interventions (MRFIs), feel experts.
College of Pharmacy, a constituent college of Gulf Medical University(GMU) is organizing a Seminar on Pharmacotherapy in the Prevention and Management of Cardiovascular Events on the February 24 at GMU Campus, Ajman.
Experts further feel that various groups of health care professionals can address the issue successfully only through a collaborative approach. Prospects for primary and secondary prevention are good if public health measures, health education, and preventive medicines are implemented based on existing knowledge of correctable or avoidable risk factors.
The aim of the lectures would be to provide insight into the causation, mechanisms and prevention of various risk factors that predispose the patients to cardiovascular complications. Various models that are currently used for risk assessment, their advantages and disadvantages will be discussed. This session will also present the various risk prediction equations for several cardiovascular disease endpoints, which are based on measurements of several known risk factors. The potential importance of controlling multiple risk factors (blood pressure, total cholesterol, high-density lipoprotein cholesterol, smoking, glucose intolerance, and left ventricular hypertrophy) as opposed to focusing on one single risk factor will be discussed.
Dr Moh’d Abu Elkhair, Advisor, Drugs & Medical Products, Health Authority of Abu Dhabi will
discuss about the Drug induced cardiovascular diseases.
Dr Lana Hammad, Director, Pharmacy Services, Rahba Hospital, Abu Dhabi will highlight
on reducing cardiovascular diseases through management of dyslipidemia.
Prof Shaik Altaf Basha Professor and Head of Department of Internal Medicine, GMC Hospital Ajman will discuss about the Pharmacotherapeutic management of cerebrovascular disease. He says that “Cerebrovascular disease is the third most common cause of death in the developed world after cancer and ischemic heart disease and is the most common cause of severe physical disability”.
Stroke is the term used to describe episodes of focal brain dysfunction due to focal ischemia or haemorrhage. Stroke is the most frequent clinical manifestation of diseases of the cerebral blood vessels, although cerebrovascular disease may present, particularly in the elderly, as a dementia. Risk factors for stroke can be subdivided into non-modifiable, modifiable, and potentially modifiable. The risk factors for ischemic stroke reflect the risk factors for the underlying vascular disease. About 5% are due to rare causes, including vasculitis, endocarditis and cerebral venous disease.
Dr S Kishore Gnana Sam, Lecturer, College of Pharmacy, Gulf Medical University, Ajman will speak about ‘Determination and prevention of various cardiovascular disease risk profiles’.
About 125 pharmacists and doctors are expected to participate in the seminar. The seminar was accredited by the Ministry of Health for 5 CME hours.